Document is current
Any future updates will be listed below
-
Authors
Fan, Yuhang
Xu, Wenchao
Gao, Bao-Qing
Qin, Huichao
Wu, Xiaoyi
Wei, Jia
Ni, Qingyang https://orcid.org/0009-0001-7727-4080
Zhou, Lina
Xiang, Jiangchao https://orcid.org/0000-0002-9918-4967
Wu, Jing
Yang, Bei https://orcid.org/0000-0001-5389-3859
Yang, Li https://orcid.org/0000-0001-8833-7473
Chen, Jia https://orcid.org/0000-0002-4242-2899
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology of the People's Republic of China (2023YFC3403402, 2024YFA1803301, 2023ZD0500501, 2024YFC3405902)
National Natural Science Foundation of China (32371514, 32070170, 32430018)
Ministry of Agriculture and Rural Affairs of the People's Republic of China (NK2022010207)
Science and Technology Commission of Shanghai Municipality (23XD1422500, 23JS1400300, 23DX1900102)
Natural Science Foundation of Shanghai (23ZR1442500)
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 21 February 2025
First Online: 25 March 2025
Competing interests
: J.C., L.Y. and B.Y. are scientific cofounders of CorrectSequence Therapeutics, a company that uses gene-editing technologies, and members of its scientific advisory board. The other authors declare no competing interests.
